CARMOL HC Drug Patent Profile
✉ Email this page to a colleague
When do Carmol Hc patents expire, and what generic alternatives are available?
Carmol Hc is a drug marketed by Fougera Pharms and is included in one NDA.
The generic ingredient in CARMOL HC is hydrocortisone acetate. There are sixty-seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydrocortisone acetate profile page.
Summary for CARMOL HC
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 90 |
Patent Applications: | 3,817 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CARMOL HC at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CARMOL HC
US Patents and Regulatory Information for CARMOL HC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fougera Pharms | CARMOL HC | hydrocortisone acetate | CREAM;TOPICAL | 080505-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |